Last 7 days
1.4%
Last 30 days
-7.8%
Last 90 days
-10.1%
Trailing 12 Months
6.5%
Income Statement (Last 12 Months) | ||||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Revenue | 7.5% | 231,114,000 | 215,040,000 | 196,611,000 | 182,174,000 | 170,933,000 |
S&GA Expenses | 2.1% | 264,490,000 | 258,971,000 | 256,524,000 | 248,971,000 | 239,984,000 |
R&D Expenses | -1.9% | 281,026,000 | 286,408,000 | 391,548,000 | 347,168,000 | 423,308,000 |
EBITDA | 25.6% | -434,838,000 | -584,637,000 | -520,108,000 | -545,684,000 | - |
EBITDA Margin | 32.0% | -2.02 | -2.97 | -2.86 | -3.19 | - |
Earnings Before Taxes | 7.5% | -410,036,000 | -443,065,000 | -592,612,000 | -527,494,000 | -552,482,000 |
EBT Margin | 31.6% | -2.06 | -3.01 | -2.90 | -3.23 | - |
Interest Expenses | - | 0.00 | - | - | - | - |
Net Income | 7.5% | -410,036,000 | -443,286,000 | -593,342,000 | -528,564,000 | -553,955,000 |
Net Income Margin | 31.7% | -2.06 | -3.02 | -2.90 | -3.24 | - |
Free Cahsflow | 10.4% | -392,227,000 | -437,894,000 | -472,046,000 | -493,213,000 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Assets | -4.1% | 1,170 | 1,220 | 1,299 | 1,419 | 1,501 |
Current Assets | -4.6% | 1,072 | 1,124 | 1,210 | 1,336 | 1,393 |
Cash Equivalents | -12.8% | 880 | 1,008 | 1,119 | 681 | 847 |
Inventory | 21.5% | 38.00 | 32.00 | 29.00 | 23.00 | 20.00 |
Net PPE | 0.8% | 58.00 | 58.00 | 51.00 | 46.00 | 45.00 |
Liabilities | -3.3% | 169 | 175 | 193 | 207 | 193 |
Current Liabilities | -10.9% | 125 | 140 | 156 | 169 | 155 |
Shareholder's Equity | -4.2% | 1,001 | 1,046 | 1,106 | 1,212 | 1,308 |
Retained Earnings | -2.6% | -1,910 | -1,861 | -1,799 | -1,638 | -1,500 |
Additional Paid-In Capital | 0.6% | 2,911 | 2,893 | 2,877 | 2,857 | 2,839 |
Accumulated Depreciation | 6.2% | 20.00 | 19.00 | 18.00 | - | - |
Shares Outstanding | 0.4% | 964 | 960 | 960 | 958 | 957 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 |
Cashflow From Operations | 4.9% | -349 | -367 | -411 | -445 | -466 |
Share Based Compensation | 6.9% | 66.00 | 61.00 | 58.00 | 50.00 | 46.00 |
Cashflow From Investing | -5.7% | 396 | 420 | 143 | -631 | -522 |
Cashflow From Financing | -239.5% | -5.87 | -1.73 | -1.81 | -2.99 | 821 |
86.9%
57.7%
41.9%
Y-axis is the maximum loss one would have experienced if Zai Lab was unfortunately bought at previous high price.
5.3%
-22.1%
FIve years rolling returns for Zai Lab.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-05-22 | AMERIPRISE FINANCIAL INC | added | 20.69 | 161,487 | 686,487 | -% |
2023-05-18 | JPMORGAN CHASE & CO | added | 212 | 6,688,000 | 9,495,000 | -% |
2023-05-18 | INTERNATIONAL BIOTECHNOLOGY TRUST PLC | unchanged | - | 202,922 | 2,626,140 | 0.73% |
2023-05-18 | NEW YORK STATE COMMON RETIREMENT FUND | reduced | -1.38 | 1,000 | 21,000 | -% |
2023-05-17 | Advisory Services Network, LLC | unchanged | - | 128 | 1,663 | -% |
2023-05-16 | RBF Capital, LLC | unchanged | - | 37,900 | 498,900 | 0.04% |
2023-05-16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | reduced | -48.19 | -716,070 | 916,280 | -% |
2023-05-16 | JANE STREET GROUP, LLC | sold off | -100 | -746,194 | - | -% |
2023-05-16 | Rockefeller Capital Management L.P. | sold off | -100 | - | - | -% |
2023-05-16 | Susquehanna International Group Ltd. | new | - | 958,121 | 958,121 | 0.54% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | qiming venture partners iv, l.p. | 8.1% | 79,229,320 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 0.6% | 5,701,440 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 0.00% | 0 | SC 13G/A | |
Jul 05, 2022 | baillie gifford & co | 4.79% | 46,935,800 | SC 13G/A | |
Feb 14, 2022 | qiming venture partners iv, l.p. | 8.2% | 7,922,932 | SC 13G/A | |
Feb 14, 2022 | du ying | 4.78% | 4,742,042 | SC 13G/A | |
Feb 14, 2022 | invesco ltd. | 7.6% | 7,286,493 | SC 13G | |
Feb 11, 2022 | capital world investors | 5.5% | 5,294,950 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
May 09, 2023 | 10-Q | Quarterly Report | |
May 09, 2023 | 8-K | Current Report | |
May 01, 2023 | ARS | ARS | |
Apr 28, 2023 | DEF 14A | DEF 14A | |
Apr 18, 2023 | PRE 14A | PRE 14A | |
Apr 05, 2023 | 4 | Insider Trading | |
Apr 05, 2023 | 4 | Insider Trading | |
Apr 05, 2023 | 4 | Insider Trading | |
Apr 05, 2023 | 4 | Insider Trading | |
Apr 05, 2023 | 4 | Insider Trading |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-04-03 | Cho William Ki Chul | acquired | - | - | 2,827 | chief financial officer |
2023-03-31 | Reinhart Harald | sold (taxes) | -35,222 | 33.26 | -1,059 | see remarks |
2023-03-31 | Edmondson Frazor Titus III | sold (taxes) | -31,696 | 33.26 | -953 | chief legal officer |
2023-03-31 | Du Ying | acquired | 472,292 | 33.26 | 14,200 | chairperson & ceo |
2023-03-31 | Du Ying | sold (taxes) | -185,857 | 33.26 | -5,588 | chairperson & ceo |
2023-03-31 | Reinhart Harald | acquired | 144,614 | 33.26 | 4,348 | see remarks |
2023-03-31 | Edmondson Frazor Titus III | acquired | 116,410 | 33.26 | 3,500 | chief legal officer |
2023-03-06 | Du Ying | gifted | - | - | -852 | chairperson & ceo |
2023-03-06 | Du Ying | sold (taxes) | -4,902,740 | 40.55 | -120,906 | chairperson & ceo |
2023-03-06 | Du Ying | acquired | 180,000 | 0.6 | 300,000 | chairperson & ceo |
Unaudited Condensed Consolidated Statements of Operations - USD ($) | 3 Months Ended | |
---|---|---|
Mar. 31, 2023 | Mar. 31, 2022 | |
Revenues: | ||
Product revenue, net | $ 62,797,000 | $ 46,095,000 |
Collaboration revenue | 0 | 629,000 |
Total revenues | 62,797,000 | 46,724,000 |
Expenses: | ||
Cost of sales | (21,337,000) | (15,643,000) |
Research and development | (48,472,000) | (53,854,000) |
Selling, general, and administrative | (62,510,000) | (56,991,000) |
Loss from operations | (69,522,000) | (79,764,000) |
Interest income | 10,232,000 | 188,000 |
Foreign currency gain | 8,912,000 | 2,285,000 |
Other income (expenses), net | 1,234,000 | (4,882,000) |
Loss before income tax and share of loss from equity method investment | (49,144,000) | (82,173,000) |
Income tax expense | 0 | 0 |
Share of loss from equity method investment | 0 | (221,000) |
Net loss | (49,144,000) | (82,394,000) |
Net loss attributable to ordinary shareholders - basic | (49,144,000) | (82,394,000) |
Net loss attributable to ordinary shareholders - diluted | $ (49,144,000) | $ (82,394,000) |
Loss per share/ADS - basic (in dollars per share) | $ (0.05) | $ (0.09) |
Loss per share/ADS - diluted (in dollars per share) | $ (0.05) | $ (0.09) |
Weighted-average shares/ADSs used in calculating net loss per ordinary share/ADS - basic (in shares) | 961,444,780 | 955,499,030 |
Weighted-average shares/ADSs used in calculating net loss per ordinary share/ADS - diluted (in shares) | 961,444,780 | 955,499,030 |
American Depositary Shares | ||
Expenses: | ||
Loss per share/ADS - basic (in dollars per share) | $ (0.51) | $ (0.86) |
Loss per share/ADS - diluted (in dollars per share) | $ (0.51) | $ (0.86) |
Weighted-average shares/ADSs used in calculating net loss per ordinary share/ADS - basic (in shares) | 96,144,478 | 95,549,903 |
Weighted-average shares/ADSs used in calculating net loss per ordinary share/ADS - diluted (in shares) | 96,144,478 | 95,549,903 |
Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands | Mar. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 879,844 | $ 1,008,470 |
Short-term investments | 50,550 | 0 |
Accounts receivable (net of allowance for credit loss of $13 and $11 as of March 31, 2023 and December 31, 2022, respectively) | 43,346 | 39,963 |
Notes receivable | 17,381 | 8,608 |
Inventories, net | 38,405 | 31,621 |
Prepayments and other current assets | 42,772 | 35,674 |
Total current assets | 1,072,298 | 1,124,336 |
Restricted cash, non-current | 1,003 | 803 |
Long term investments (including the fair value measured investment of $6,872 and $6,431 as of March 31, 2023 and December 31, 2022, respectively) | 6,872 | 6,431 |
Prepayments for equipment | 1,721 | 1,396 |
Property and equipment, net | 58,309 | 57,863 |
Operating lease right-of-use assets | 20,148 | 19,512 |
Land use rights, net | 6,920 | 6,892 |
Intangible assets, net | 1,479 | 1,511 |
Long-term deposits | 1,324 | 1,396 |
Total assets | 1,170,074 | 1,220,140 |
Current liabilities: | ||
Accounts payable | 66,361 | 65,974 |
Current operating lease liabilities | 7,318 | 7,050 |
Other current liabilities | 50,881 | 66,818 |
Total current liabilities | 124,560 | 139,842 |
Deferred income | 30,968 | 21,360 |
Non-current operating lease liabilities | 12,979 | 13,343 |
Other non-current liabilities | 325 | 0 |
Total liabilities | 168,832 | 174,545 |
Commitments and contingencies (Note 15) | ||
Shareholders’ equity | ||
Ordinary shares (par value of $0.000006 per share; 5,000,000,000 shares authorized; 967,197,350 and 962,455,850 shares issued as of March 31, 2023 and December 31, 2022, respectively; 963,688,740 and 960,219,570 shares outstanding as of March 31, 2023 and December 31, 2022, respectively) | 6 | 6 |
Additional paid-in capital | 2,911,454 | 2,893,120 |
Accumulated deficit | (1,910,504) | (1,861,360) |
Accumulated other comprehensive income | 17,272 | 25,685 |
Treasury Stock (at cost, 3,508,610 and 2,236,280 shares as of March 31, 2023 and December 31, 2022, respectively) | (16,986) | (11,856) |
Total shareholders’ equity | 1,001,242 | 1,045,595 |
Total liabilities and shareholders’ equity | $ 1,170,074 | $ 1,220,140 |